Nephrotic syndrome secondary to alpha-1 antitrypsin deficiency
- PMID: 33674298
- PMCID: PMC7938990
- DOI: 10.1136/bcr-2020-240288
Nephrotic syndrome secondary to alpha-1 antitrypsin deficiency
Abstract
We report a 64-year-old caucasian woman diagnosed with membranous nephropathy secondary to alpha-1 antitrypsin deficiency (AATD). AATD is a rare autosomal codominant genetic disorder. Its clinical manifestations are mostly observed in the lungs, with early-onset emphysema. Nephropathy due to AATD is still very rare and only a few cohort studies have been reported. It has been recognised that alpha-1 antitrypsin has a protective role in the kidneys which enhances the possibility of development of kidney failure, such as nephrotic syndrome, in cases of AATD. Further clinical investigation is needed to understand the relationship between the development of nephropathy, namely membranous nephropathy, and AATD.
Keywords: genetics; nephrotic syndrome; pulmonary emphysema.
© BMJ Publishing Group Limited 2021. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: None declared.
Figures

References
-
- Hobbs BD, Silverman E, Cho M. Genetics and epidemiology. : Strnad P, Brantly ML, Bals R, . α1-Antitrypsin deficiency ERS monograph sheffield. European Respiratory Society, 2019: 27–38.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical